The consequences of greater net price transparency for innovative medicines in Europe

• Life Sciences
• Reports

Understanding the relationship between the 32-item motor function measure and daily activities from an individual with spinal muscular atrophy and their caregivers’ perspective: a two-part study

The 32-item Motor Function Measure (MFM32) is a clinician-reported outcome measure used to assess the functional abilities of individuals with neuromuscular...

• Life Sciences
• CRA Hosted Event

• April 13, 2021
• Virtual Webinar

The European Commission’s new Pharmaceutical Strategy: Understanding key policy objectives

The European Commission has recently published a comprehensive package of regulatory reforms for the pharmaceutical sector in the European Union (EU), setting...

• Life Sciences
• Sponsorship

• June 11, 2021

The Leukemia & Lymphoma Society’s 2021 New England Man & Woman of the Year

CRA is proud to support the New England region of the LSS Man & Woman of the year campaign, a philanthropic competition to support blood cancer research. Ned...